Form 8-K - Current report:
SEC Accession No. 0001193125-25-070496
Filing Date
2025-04-01
Accepted
2025-04-01 16:38:57
Documents
13
Period of Report
2025-04-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d945427d8k.htm   iXBRL 8-K 29978
  Complete submission text file 0001193125-25-070496.txt   156432

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bold-20250401.xsd EX-101.SCH 2853
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bold-20250401_lab.xml EX-101.LAB 18737
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bold-20250401_pre.xml EX-101.PRE 11709
15 EXTRACTED XBRL INSTANCE DOCUMENT d945427d8k_htm.xml XML 3766
Mailing Address 10955 ALEXANDRIA WAY SUITE 100 SAN DIEGO CA 92121
Business Address 10955 ALEXANDRIA WAY SUITE 100 SAN DIEGO CA 92121 (858) 766-9912
Boundless Bio, Inc. (Filer) CIK: 0001782303 (see all company filings)

EIN.: 830751369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41989 | Film No.: 25800361
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)